A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate

NCT02171143 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Pharmacokinetics of ASP2409

Interventions

DRUG: ASP2409
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.